Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SimulCare II(TM)

K-Number: K160246 · 2016-10-06

Decision Date2016-10-06
Product CodeGZJ
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

SimulCare II(TM) is the device name listed in this FDA 510(k) record. The listed applicant is Xanacare Technologies, LLC. It received FDA 510(k) clearance on 2016-10-06 under 510(k) number K160246. The device is classified under product code GZJ. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SimulCare II(TM)?

SimulCare II(TM) is a medical device that received FDA 510(k) clearance on 2016-10-06. The listed applicant is Xanacare Technologies, LLC. The 510(k) number is K160246.

When did SimulCare II(TM) receive FDA 510(k) clearance?

SimulCare II(TM) received FDA 510(k) clearance on 2016-10-06, under 510(k) number K160246.

Who is the listed applicant for SimulCare II(TM)?

The FDA 510(k) record lists Xanacare Technologies, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SimulCare II(TM)?

The FDA product code for SimulCare II(TM) is GZJ.

Related Devices (Code: GZJ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.